Free Malaysia Today reports that price is holding back use of weight loss drugs in developing markets, where penetration rates remain low.
Recap by typeshit. Post by Free Malaysia Today on X.
The new Medicare program could cut GLP-1 costs by thousands for people on it, though many beneficiaries will not meet the eligibility rules.
KTSM breaks down which Medicare enrollees are eligible for GLP-1 drugs at a $50 monthly cost.
Men's Journal looks at the extra spending that comes with GLP-1 drugs beyond the prescription price, as these meds reshape weight loss.
The Times reports plans that could put Wegovy on Ireland's public health service, a potential shift in who can get the drug without paying privately.
Consultancy AlixPartners looked at what weight loss drugs mean for clothing companies, as shoppers on GLP-1s change sizes and buying habits.
New IQVIA numbers show Foundayo prescriptions falling to 58,014 from 60,151 the week before, while Novo's pill held roughly flat.
Loading…